Maximus Review

Maximus: a men's optimization brand that added GLP-1, not a weight-loss clinic that added everything else

Maximus built its name on testosterone and longevity protocols for men, and that origin tells you most of what you need to know before signing up for its weight-loss program. Compounded semaglutide and tirzepatide are real offerings here, available in all 50 states plus DC, but they sit alongside TRT and other men's-health treatments rather than being the main event. If you're a man who wants to lose weight while also working with a platform that handles hormones and broader optimization, that bundling is the whole appeal. If you just want a focused, no-frills GLP-1 program, you're shopping at a store where weight loss is one aisle, not the front door.

How the pricing actually works: flat monthly, every dose included

Maximus uses a flat-rate model, which is genuinely the most patient-friendly part of the offer. Compounded semaglutide starts at $249.99 a month, and that single price includes access to all dose tiers — so when your prescriber moves you up the dose ladder, your bill doesn't climb with it. That matters, because plenty of compounding telehealth brands quietly raise the monthly charge each time your dose increases. The dual-action tirzepatide plan runs noticeably higher, in the mid-two-hundreds per month, but follows the same all-tiers-included logic. For comparison, the category median across providers we track sits at $169, so Maximus's semaglutide plan lands below the middle of the pack while its tirzepatide plan sits above it.

Medication and shipping are folded into that monthly price, and Maximus advertises free, discreet shipping — a small but real plus for anyone who'd rather their packages not announce what's inside.

One pricing caveat worth reading the fine print on

Maximus's refund language refers to returning your money "minus the cost of the doctor consultation," which strongly implies there's a consultation charge baked in somewhere even though the company doesn't spell it out as a separate headline line. Before you commit, ask support directly what the upfront visit costs and what's actually refundable if the program isn't for you. Don't assume the monthly figure is the only money that leaves your account.

The medications: compounded only, with a microdose option that's actually thoughtful

Everything Maximus dispenses for weight loss is compounded — there are no brand-name Wegovy or Zepbound options here. That keeps the price down but means you're relying on a compounding pharmacy's formulation rather than an FDA-approved finished product, the standard trade-off across this corner of telehealth. You get the two workhorse molecules: semaglutide (the GLP-1 in Ozempic and Wegovy) and tirzepatide (the dual GLP-1/GIP agent in Mounjaro and Zepbound).

The standout clinical touch is the microdose protocol. Maximus offers lower-dose GLP-1 plans aimed at people who don't have a large amount of weight to lose — someone targeting the last ten or fifteen pounds rather than a major reduction. A lot of providers only think in terms of the standard escalating dose ladder, so a deliberate low-dose lane is a genuine point of difference and a sign someone designed the program around real patient variety.

Where the trust questions are real

This is the part to take seriously. Maximus doesn't display LegitScript certification or PCAB accreditation for its compounding supply chain. Some competitors put those credentials front and center. On top of that, third-party reviewers have reported a BBB F rating, with complaints specifically about prescriptions that weren't fulfilled. That's not a minor cosmetic gripe; an unfilled prescription is the one failure that actually defeats the purpose of paying for the service.

None of that means the medication you receive is unsafe; the molecules themselves are well-studied. The platform does have an FDA warning letter on file, covered in the regulatory notice below. And the absence of visible accreditation plus documented fulfillment complaints is exactly the kind of operational risk that should temper your expectations. Start with a single month before committing to anything longer. You can read how we weigh these signals in our scoring methodology.

Who should choose Maximus, and who should walk

Maximus makes the most sense for one specific person: a man who wants to combine GLP-1 weight loss with testosterone or broader optimization under a single login, and who values the flat all-doses-included pricing enough to accept the trust caveats. The microdose option also makes it worth a look for anyone — within its men's-health framing — chasing a modest amount of weight loss rather than a dramatic one.

• Good fit: men already interested in TRT or longevity care who want weight loss bundled in
• Good fit: patients who want predictable pricing that doesn't rise with each dose increase
• Good fit: people targeting a smaller amount of weight loss who want a true microdose plan
• Skip it: anyone who wants brand-name semaglutide or tirzepatide rather than compounded
• Skip it: women, or anyone wanting a dedicated weight-loss clinic where GLP-1 is the primary focus
• Skip it: patients who won't proceed without visible LegitScript/PCAB credentials and a clean complaint record

Bottom line

Maximus offers a legitimately appealing structure — flat monthly pricing with all dose tiers included, a thoughtful microdose lane, nationwide availability, and the convenience of weight loss alongside men's hormone care. The semaglutide plan in particular is priced below the category median. But the unanswered consultation-fee question, the missing compounding accreditations, and the reported fulfillment complaints are real reasons to go in cautiously. If you're the man this platform was built for, start with one month, confirm every charge in writing before you pay, and judge the fulfillment for yourself before you rely on it long-term.

For a side-by-side, Direct Meds ($249/month) and Collective ($59/month) are the most comparable options to weigh against Maximus.